2003 Clinical Milestones
Region
Product
Milestone
US
US
US
US
US
US
US
US
US
Influenza Vaccine
INTERCEPT Plasma
INTERCEPT RBC
Next-Generation IVIG
Flex Albumin
Recombinant AAT
Ceprotin
Hemofil M DVI
Next-Gen FEIBA
Initiate Phase III
Complete Patient Enrollment
Complete Patient Enrollment
Submission for Approval
File BLA
Dose 1st Patient in Phase I
Begin Phase II/III Study
File IND
File IND
Europe
Europe
Europe
Europe
US
Chemoprotectant Drug
Hormonal Drug
D24851 (Breast Cancer)
D70166 (Breast Cancer)
Insulin Microspheres
Continue Phase III Enrollment
Start and Complete Phase II
Complete Phase I
Initiate Phase I
Initiate Phase I
EPOMAX
EPOMAX
Physioneal
Lineo Connectology
W. Europe
Japan
Japan
US/Canada/ Europe
Initiate Phase III
Initiate Phase I
Complete Patient Enrollment
Submission for Approval
Previous slide
Next slide
Back to first slide
View graphic version